Archive for March, 2009

Running The Numbers – Cisco ($CSCO) Cheap Below US$20 A Share

Tuesday, March 31st, 2009

Cisco Systems ($CSCO) has traditionally been a designer, manufacturer and seller of network and communications technology and services. Two weeks ago the company generic cialis no prescription

83736001.html?mg=com-wsj”>announced a significant shift in strategy by beginning to compete with Hewlett-Packard ($HPQ) in the broader server market. A week earlier $CSCO had announced a deeper move into the consumer electronics business with the acquisition of Pure Digital. Very interesting times for $CSCO. We decided to have a look at some numbers for $CSCO to estimate an intrinsic valuation for the shares.

Valuecruncher Interactive Analyst Report For $CSCO – New Format

Valuecruncher produces a valuation of US$20.39 for $CSCO. This is a current valuation (an estimate of intrinsic value using a discounted cash flow model) not a target price. This valuation is 20.3% above the current share price of US$16.95.

Assumptions

  • Revenue: Reuters aggregates 27 analysts covering $CSCO and the mean estimates of 2009 and 2010 revenues are US$35.9 billion and US$34.8 billion respectively. For our analysis we have used US$36.0 billion in 2009, US$35.0 billion in 2010 and US$40.0 billion in 2011.
  • Profitability: We have used an EBITDA margin of 28.0% in 2009 dropping to 26.5% in 2010 then rising back to 28% in 2011. Reuters has $CSCO‘s EBITD margin at 27.1% last year and an average of 30.6% over the last five-years.
  • Capital Expenditure: We have assumed capital expenditures of US$1.15 billion in 2009, US$1.05 billion in 2010 then US$1.35 billion per annum moving forward.
  • Discount Rate: 10.5%.
  • Terminal Growth Rate: 4.0%. In our assumptions we have 2010/11 revenue growth at 14.3% – we have assumed that growth eventually slows to a 3.0% long-term stable growth rate.

Our analysis incorporates the cash and debt on the $CSCO balance sheet – Valuecruncher calculates a net debt number.

Play with our assumptions – what does your analysis say? Our model is interactive – you can change any of our assumptions.

Disclosure: None


Running The Numbers – Revisiting Google ($GOOG). Cheap Below US$370

Saturday, March 21st, 2009

We last looked at Google ($GOOG) in mid-December. We decided to run some numbers and have a look at the intrinsic value of the com

buy generic cialis online

pany. $GOOG is currently trading at US$330.16 – how does this compare with an estimate of the underlying value of the shares?

Valuecruncher Interactive Analyst Report For $GOOG – New Format

Valuecruncher produces a valuation of US$369.98 for $GOOG. This is a current valuation (an estimate of intrinsic value using a discounted cash flow model) not a target price. This valuation is 12.1% above the current share price of US$330.16.

Assumptions

  • Revenue: Reuters aggregates 25 analysts covering $GOOG and the mean estimates of 2009 and 2010 revenues are US$23.3 billion and US$26.6 billion respectively. For our analysis we have used US$23.3 billion in 2009, US$26.5 billion in 2010 and US$31.0 billion in 2011.
  • Profitability: We have used an EBITDA margin of 40.0% to 2011. Reuters has $GOOG‘s EBITD margin at 32.25% last year and an average of 34.8% over the last five-years. Reuters use EBITD not EBITDA that we at Valuecruncher use and this explains the difference between our numbers and Reuters. The missing “A” is amortization – the accounting treatment of the acquisition cost of intangible assets (depreciation is the same for tangible assets). For a technology company like $GOOG this is material – for $GOOG amortization was US$270 million in 2008.
  • Capital Expenditure: We have assumed capital expenditures of US$2.75 billion in 2009 then US$3.0 billion per annum moving forward.
  • Discount Rate: 10.5%.
  • Terminal Growth Rate: 5.0%. In our assumptions we have 2010/11 revenue growth at 17.0% – we have assumed that growth eventually slows to a 4.0% long-term stable growth rate.

Our analysis incorporates the cash on the $GOOG balance sheet – Valuecruncher calculates a net debt number.

Play with our assumptions – what does your analysis say? Our model is interactive – you can change any of our assumptions.

Disclosure: None

Valuing The New Zealand Stock Market (NZSX)

Thursday, March 19th, 2009

In the spirit of The Economist’sBig Mac Index“. Here at Valuecruncher we decided to undertake a small exercise to assess the overall current v

where can i buy cialis online

aluation of the New Zealand stock exchange (NZSX) – the market as a whole. Our objective was to assess whether the overall market might be over- or undervalued.

To do this we took a simplified approach. At Valuecruncher we have completed valuations for 36 of the NZX50 companies. Four of these companies are not NZ-based so we eliminated them. That leaves us with 32 companies. These 32 companies have a market capitalisation of NZ$30.2 billion – this represents just under 70% of the NZSX total market capitalisation of NZ$43.8 billion. We took these 32 companies and compared our valuations to the current share price – determining a percentage under- or overvalued. We then weighted these percentages by the market capitalisation of the 32 companies. By summing these weighted averages we came up with an estimate of the valuation of the New Zealand market.

Based on our sample of 32 companies – representing just under 70% of the total NZSX market capitalisation. Valuecruncher estimates that the New Zealand stock exchange is undervalued by just under 5%. Valuecruncher is saying that overall the market looks slightly cheap. Our numbers are included in the table below.

Hat tip to Steve Gawn at ANZ National for the idea for this analysis.

NZX Compariosn

More on this topic (What's this?)
New Zealand's Bakken
A Brief History of New Zealand Oil
Two Trades Executed
Read more on Investing in New Zealand, Cross-harbr (HLDGS) at Wikinvest

The Death of Equites: Not Quite

Thursday, March 19th, 2009

We are a little bit late with this piece – but we wanted to highlight it anyway. James Berman has a fantastic piece of analysis in The Huffington Post<

From Newbie To Millionaire

/a> called Reports of the Death of Equities: Greatly Exaggerated. In the article Berman makes a very clear case for the fundamental valuation of equities and the understanding of concepts like intrinsic value. We strongly recommend the article as outlining a framework similar to how we here at Valuecruncher look at valuing companies.

On understanding why intrinsic value matters

“To understand why intrinsic value matters, we need to step away from the panic and the bleak macro picture to understand that stocks are valued on earnings or cash flows. The latter is preferable because it strips out the accounting fictions of depreciation, amortization, goodwill write-downs and other non-cash charges. I teach my NYU students to follow the cash flows, not the earnings, because cash is what a business actually runs on.

Let’s take the example of Automatic Data Processing, or ADP (which is a core holding in both the Torray Fund, which we own for clients in separate accounts, and in the JBGlobal Fund L.P.). ADP is the largest payroll processor, the leader in a tremendously stable and unglamorous business. Due to rising unemployment, its stock has been hit hard, despite the fact that ADP has virtually no debt, an enormous cash position, healthy cash flows (even in this severe recession), and virtually no chance of going bust. I chose ADP but I could have chosen so many of the stocks now trading on the Dow, given how undervalued stocks are on a global basis.

ADP is currently trading at $32 per share, or 9 times its operating cash flows of $3.50 per share. In 1999 it was around four times as expensive, trading at 37 times cash flows. In effect, it is selling at a 76% discount to its 1999 price. People get excited when a pair of shoes, a car or a house sell at a 76% discount — but not stocks. As Benjamin Graham (the father of value investing and Warren Buffett’s mentor) liked to say, you should buy your stocks like you do your groceries, not as you do your jewelry: you should be happy to buy a stock when it’s on sale, even if a bleak environment is responsible for the sales price. As value investors often preach, you pay a dear price for a cheery consensus.”

The Valuecruncher interactive analyst report for ADP agrees that the stock is undervalued.

And on Warren Buffett

“Warren Buffett readily admits that his secret in acquiring enormous wealth was not vastly superior intelligence, prescience, or any trading strategy — but in always looking at stocks for what they really were: claims on the underlying cash flows of a business. Instead of trying to time the market, trade in and out, predict macroeconomic trends or divine the next stimulus package, he simply tried to buy businesses selling at reasonable prices relative to their cash flow and hold them for long periods of time — as they increased in value — often “forever.”

His secret was in understanding that when the price of a valuable business goes down, it’s time to buy, not sell. This understanding allowed him to hold stocks during the paralyzing market of the Seventies. At that time, the world seemed like it was coming to an end with Watergate, war in the Middle East, Vietnam, horrible inflation, recession, price controls, gas shortages, double digit unemployment and riots in the streets. But he held and bought more stocks (as he is now) because he understood the value at such prices.”

Well worth the read.

What To Buy On The NZX – New Zealand Stock Exchange

Saturday, March 14th, 2009

With the launch of our new interactive analyst reports we complete a monthly review of the approximately 750 valuations in our data-set. This inv

Bvcures.com — Powered By Webseeds.com – *proven Products

olves a review of the assumptions we are using in the valuations. We use consensus analyst estimates as the basis of our assumptions. For example – consensus analyst estimates of revenues for New Zealand’s largest listed company Telecom New Zealand ($TEL.NZ). Valuecruncher uses these numbers and our own assessments of other valuation assumptions such as the discount rate and terminal growth rate.

At Valuecruncher we then pull all of these variables together and place a valuation on the shares of the companies in our data-set and provide a recommendation. You can either simply look at our valuations – or for all the experts out there, you can change the assumptions we have used and modify the valuation. Modified valuations can be saved and shared.

With the completion of our monthly review of the companies on the NZX (New Zealand stock exchange) we decided to outline what we at Valuecruncher see as the most undervalued (the best buys).

We should note that you can always find a list of the Valuecruncher buy recommendations for the NZX from the most undervalued using our filters. The following list highlights the top five buys based on the latest review of the valuation assumptions.

Valuecruncher’s Top Five Buys On The NZX – March 2009

Number 1

Michael Hill International ($MHI.NZ) is a New Zealand-based jewelry retailer and manufacturer. Valuecruncher currently values $MHI.NZ at NZ$0.71 – 39% above the current share price.

Valuecruncher Interactive Analyst Report For $MHI.NZ

Number 2

Sky Network Television ($SKT.NZ) is a provider of pay and free-to-air television services in New Zealand. Valuecruncher currently values $SKT.NZ at NZ$5.06 – 33% above the current share price.

Valuecruncher Interactive Analyst Report For $SKT.NZ

Number 3

Hallenstein Glasson Holdings ($HLG.NZ) is a NZX-listed clothing retailer. Valuecruncher currently values $HLG.NZ at NZ$2.49 – 26% above the current share price.

Valuecruncher Interactive Analyst Report For $HLG.NZ

Number 4

Air New Zealand ($AIR.NZ) is an international and domestic airline based in New Zealand. Valuecruncher currently values $AIR.NZ at NZ$1.11 – 24% above the current share price.

Valuecruncher Interactive Analyst Report For $AIR.NZ

Number 5

Methven ($MVN.NZ) is a New Zealand company that designs and supplies taps and shower-ware. Valuecruncher currently values $MVN.NZ at NZ$1.27 – 18% above the current share price.

Valuecruncher Interactive Analyst Report For $MVN.NZ

Those are our top five buys for March 2009. You can also always find a list of the Valuecruncher sell recommendations for the NZX from most overvalued up using our filters.

Disclosure: None

More on this topic (What's this?)
New Zealand's Bakken
A Brief History of New Zealand Oil
Two Trades Executed
Read more on Investing in New Zealand at Wikinvest

Running The Numbers – Michael Hill International ($MHI.NZ) Revisited

Wednesday, March 11th, 2009

At Valuecruncher we looked at Michael Hill International ($MHI.NZ) back generic cialis no prescription

chael-hill-international-mhinz/”>in November last year. $MHI.NZ is a New Zealand listed jewelry retailer and manufacturer. In November 2008 we placed a value on $MHI.NZ of NZ$0.88 per share. In November $MHI.NZ was trading at NZ$0.66. $MHI.NZ has continued to track downwards – currently trading at NZ$0.51. We decided to review our previous valuation and look at the current share price.

Valuecruncher Interactive Analyst Report For $MHI.NZ (New Format)

Valuecruncher produces a valuation of NZ$0.70 for $MHI.NZ. This is a current valuation (an estimate of intrinsic value using a discounted cash flow model) not a target price. This valuation is 37.25% above the current share price of NZ$0.51.

Assumptions

  • Revenue: Reuters aggregates two analysts covering $MHI.NZ and the mean estimates of 2009 and 2010 revenues are NZ$412.1 million and NZ$426.6 million respectively. For our analysis we have used NZ$410.0 million in 2009, NZ$425.0 million in 2010 and NZ$450.0 million in 2011. Previously we had revenues of NZ$440.0 million in 2010 and NZ$480.0 million in 2011.
  • Profitability: We have used a flat EBITDA margin of 11.0% to 2011. Reuters has $MHI.NZ‘s EBITD margin at 10.7% last year and an average of 12.1% over the last five-years. Previously we used a flat 12.0% EBITDA margin.
  • Capital Expenditure: We have assumed capital expenditures of NZ$16.0 million per annum moving forward. This is the same as our previous analysis.
  • Discount Rate: 10.0%. The PwC New Zealand cost of capital report has $MHI.NZ at a WACC of 10.9% with the wider NZ market at 9.1%. Previously we used 10.0% with PwC giving $MHI.NZ a WACC of 7.8%. We have kept our discount rate at the same level as our previous analysis. The movement in PwC’s cost of capital report is significant.
  • Terminal Growth Rate: 3.0%. This is the same as our previous analysis.

Our analysis incorporates the cash and debt on the $MHI.NZ balance sheet – Valuecruncher calculates a net debt number.

Play with our assumptions – what does your analysis say?

Disclosure: None

More on this topic (What's this?)
Looks Good, But How Does It Smell?
Read more on Hill International Inc at Wikinvest

Running The Numbers – Raytheon ($RTN) Undervalued Below US$45 A Share

Wednesday, March 11th, 2009

Aerospace and defence contractor Raytheon ($RTN) has seen it’s share price drop from a 52-week high of US$67.37 to close to a 52-week low at US$34.61. At Valuecruncher we decided to have a look at the company’s

canadian pharmacy

financial and put together an estimate of intrinsic value.

Valuecruncher Interactive Analyst Report For $RTN (New Format)

Valuecruncher produces a valuation of US$45.87 for $RTN. This is a current valuation (an estimate of intrinsic value using a discounted cash flow model) not a target price. This valuation is 32.5% above the current share price of US$34.61. $RTN is currently well below our estimate of intrinsic value.

Assumptions

  • Revenue: Reuters aggregates 12 analysts covering $RTN and these analysts have a mean estimates of 2009 and 2010 revenues of US$24.6 billion and US$25.9 billion respectively. For our analysis we have used US$24.5 billion in 2009, US$25.5 billion in 2010 and US$26.5 billion in 2011.
  • Profitability: We have used an EBITDA margin of 11.5% flat to 2011. Reuters has $RTN‘s EBITD margin at 12.9% last year with a five-year average of 11.4%
  • Capital Expenditure: We have assumed capital expenditures of US$375.0 million in 2009 rising to US$400.0 million in 2010 and beyond.
  • Discount Rate: 11.0%.
  • Terminal Growth Rate: 1.5%. This is a conservative growth rate. Valuecruncher believes that a growth rate between 1.5% and 3.0% would be reasonable.

Our analysis incorporates the cash and debt the $RTN balance sheet – Valuecruncher calculates a net debt number.

Play with our assumptions – what does your analysis say?

Disclosure: None


More on this topic (What's this?) Read more on Raytheon Company at Wikinvest

Valuecruncher Launches New Homepage

Tuesday, March 10th, 2009

Today we have launched a new homepage for Valuecruncher. This is all about our new interactive analyst re

buy cheap cialis online

port offering.

Valuecruncher has interactive analyst reports for 745 companies in the S&P500 (US), FTSE350 (UK), TSX Composite (Canada), ASX200 (Australia) and NZX50 (NZ).

The new homepage makes it easy for you to search for companies that you are interested in or to simply look for companies we think are a buy or a sell. Our interactive analyst reports are based on a discounted cash flow valuation approach. You can modify our assumptions and the valuation will be updated automatically. You can also save and share your valuation.

We continue to work out the kinks. We would love to hear your thoughts.

More on this topic (What's this?)
Equal Weighted S&P 500 Index Insights
Canada Desperate for Keystone XL
Read more on For You, China Railsmedia, S&P/TSX Composite Index (GSPTSE) at Wikinvest

Running The Numbers – Johnson & Johnson ($JNJ) Undervalued Below US$55 A Share

Monday, March 9th, 2009

The news (via a 13F release) that Warren Buffett’s Berkshire Hathaway ($BRK.A) had significantly reduced

order cheap cialis online

their holding in Johnson & Johnson ($JNJ) has added to the existing pressure on the $JNJ share price. $JNJ has dropped 33.6% in the last six months. At Valuecruncher we decided to have a look at the intrinsic value of $JNJ.

Valuecruncher Interactive Analyst Report For $JNJ (New Format)

Valuecruncher produces a valuation of US$55.65 for $JNJ. This is a current valuation (an estimate of intrinsic value using a discounted cash flow model) not a target price. This valuation is 16.0% above the current share price of US$47.97. $JNJ is currently well below our estimate of intrinsic value.

Assumptions

  • Revenue: Reuters aggregates 11 analysts covering $JNJ and these analysts have a mean estimates of 2009 and 2010 revenues of US$62.1 billion and US$64.6 billion respectively. For our analysis we have used US$62.0 billion in 2009, US$64.0 billion in 2010 and US$67.0 billion in 2011.
  • Profitability: We have used an EBITDA margin of 30% flat to 2011. Reuters has $JNJ‘s EBITD margin at 31.1% last year with a five-year average of 29.7%
  • Capital Expenditure: We have assumed capital expenditures of US$3.25 billion in 2009 and 2010 rising to US$3.5 billion in 2011 and beyond.
  • Discount Rate: 10.0%.
  • Terminal Growth Rate: 3.0%.

Our analysis incorporates the cash and debt the $JNJ balance sheet – Valuecruncher calculates a net debt number.

Play with our assumptions – what does your analysis say?

Disclosure: None

More on this topic (What's this?)
(JNJ) BioLineRx to Start BL-8040 Study
Johnson & Johnson is undervalued –Here’s why
Read more on JOHNSON & JOHNSON at Wikinvest

Running The Numbers – Pumpkin Patch ($PPL.NZ)

Sunday, March 8th, 2009

New Zealand-based children’s clothing company Pumpkin Patch ($PPL.NZ) Inside Tipster – Rebills & High Client Retention Rate

tid=10558410″>announced their half-year result in late February. The company announced a 7% drop in half-year profits – but the share price rose on the news. The reason for this is that market participants expected a larger decrease in profits and had that factored into their valuation models. The better than anticipated result meant the valuation of PPL.NZ was increased and the current share price looked cheap. This resulted in more buyers and a higher share price – you can see the jump in the graph below. With the current share price of $PPL.NZ at NZ$1.05 we decided to have a look at the intrinsic value.

Valuecruncher Interactive Analyst Report For $PPL.NZ (New Format)

Valuecruncher produces a valuation of NZ$1.07 for $PPL.NZ. This is a current valuation (an estimate of intrinsic value using a discounted cash flow model) not a target price. This valuation is 2% above the current share price of NZ$1.05.

Assumptions

Our analysis incorporates the cash and debt the $PPL.NZ balance sheet – Valuecruncher calculates a net debt number.

Play with our assumptions – what does your analysis say?

Disclosure: None

More on this topic (What's this?)
Cutting Your Losers
Read more on Pumpkin Patch at Wikinvest

Tags: ,
Posted in NZX, Pumpkin Patch | No Comments »

You are currently browsing the Valuecruncher blog archives for March, 2009.

Subscribe

Blog posts Click for updates

Categories